tirzepatide no longer shortage FDA Says for GLP-1 Is Over ⚠️Medicine shortage update - Discontinuation

Jen Simmons, a former breast cancer surgeon who has transitioned into an integrative oncologist

Signs of dehydration Including dizziness, reduced urine output despite increased frequency, dark concentrated urine, dry mouth, or confusion

Retatrutide may require particular caution or may not be suitable for individuals with: A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) based on findings in rodent studies, this is a precaution shared across the GLP-1 receptor agonist class in EU and UK product information

instead, apply gentle pressure with a clean cloth for 10 seconds